The use of oxygen in the palliation of breathlessness. A report of the expert working group of the scientific committee of the association of palliative medicine

被引:87
作者
Booth, S
Anderson, H
Swannick, M
Wade, R
Kite, S
Johnson, M
机构
[1] Addenbrookes Hosp, Ctr Oncol, Cambridge CB2 2QQ, England
[2] Wythenshawe Hosp, Manchester M23 9LT, Lancs, England
[3] Nightingale McMillan Unit, Derby DE1 2QS, England
[4] W Suffolk Hosp, Bury St Edmunds IP33 2QY, Suffolk, England
[5] Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England
[6] St Catherines Hospice, Scarborough YO12 6TB, England
关键词
dyspnoea; cancer; heart failure; COPD; palliation; oxygen;
D O I
10.1016/j.rmed.2003.08.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dyspnoea is a common, distressing symptom and difficult to control with medical treatment. The role of oxygen in reducing the severity of the symptoms and improving quality of life is still unclear. A working party of the Association of Palliative Medicine Science Committee set out to examine the evidence concerning the use of oxygen for the palliation of breathlessness in COPD, advanced cancer and chronic heart failure and to make recommendations for clinicians working in palliative care. There were very few randomised controlled traits available for any of these conditions. There was no evidence available for heart failure, very, little for advanced cancer and although there were a number of traits on the use of oxygen in COPD very few, until recently, used reduction of breathlessness as an outcome measure. Recommendations are made on the basis of the evidence available and expert opinion such as the Royal College of Physicians report on the use of domiciliary oxygen. Oxygen use has to be tailored to the individual and a format assessment made of its efficacy for reducing breathlessness and improving quality of life for that person. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:66 / 77
页数:12
相关论文
共 54 条
[1]   Effect of increased inspired oxygen concentrations on exercise capacity in stable heart failure [J].
Abinader, EG ;
Sharif, D .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (08) :1043-1044
[2]   Does oxygen help dyspnea in patients with cancer? [J].
Booth, S ;
Kelly, MJ ;
Cox, NP ;
Adams, L ;
Guz, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (05) :1515-1518
[3]   The shuttle walking test: a reproducible method for evaluating the impact of shortness of breath on functional capacity in patients with advanced cancer [J].
Booth, S ;
Adams, L .
THORAX, 2001, 56 (02) :146-150
[4]   PSYCHOPHYSICAL BASES OF PERCEIVED EXERTION [J].
BORG, GAV .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1982, 14 (05) :377-381
[5]   SYMPTOMATIC BENEFIT OF SUPPLEMENTAL OXYGEN IN HYPOXEMIC PATIENTS WITH TERMINAL CANCER - THE USE OF THE N OF 1 RANDOMIZED CONTROLLED TRIAL [J].
BRUERA, E ;
SCHOELLER, T ;
MACEACHERN, T .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (06) :365-368
[6]   EFFECTS OF OXYGEN ON DYSPNEA IN HYPOXEMIC TERMINAL-CANCER PATIENTS [J].
BRUERA, E ;
DESTOUTZ, N ;
VELASCOLEIVA, A ;
SCHOELLER, T ;
HANSON, J .
LANCET, 1993, 342 (8862) :13-14
[7]   Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure [J].
Chua, TP ;
Ponikowski, PP ;
Harrington, D ;
Chambers, J ;
Coats, AJS .
HEART, 1996, 76 (06) :483-489
[8]   Are symptoms the most important target for therapy in chronic heart failure? [J].
Cleland, JGF .
PROGRESS IN CARDIOVASCULAR DISEASES, 1998, 41 (01) :59-64
[9]  
*COPD GUID GROUP S, 1997, THORAX S5, V52, pS1
[10]   SUPPLEMENTAL OXYGEN AND EXERCISE ABILITY IN CHRONIC OBSTRUCTIVE AIRWAYS DISEASE [J].
DAVIDSON, AC ;
LEACH, R ;
GEORGE, RJD ;
GEDDES, DM .
THORAX, 1988, 43 (12) :965-971